• HOME
  • LEADERSHIP
  • TECHNOLOGY
  • PUBLICATIONS
  • CONTACT
Lobesity Pharmaceuticals and Technologies Lobesity Pharmaceuticals and Technologies
  • HOME
  • LEADERSHIP
  • TECHNOLOGY
  • PUBLICATIONS
  • CONTACT

Additional Benefits of Anti-GIP mAb

• Decreased fat deposition everywhere (abdominal cavity, liver, skin)
• Type 2 diabetes developed in the untreated animals, but not in those treated with the Anti-GIP mAb
• The lipid profile of the treated mice was normal
• Triglycerides decreased
• Total cholesterol decreased
• Low-density lipoproteins (“bad cholesterol”) decreased
• High-density lipoprotein (“good cholesterol”) ratio increased

Contact Us

Thank you for your inquiry. How can we help you today?

Send Message
Lobesity blocks obesity at its roots because we realize the importance of first understanding how obesity occurs Contact Us

© 2021 · Lobesity LLC All Rights Reserved.